Breaks Categories: Stock Spotlights

ThursdayDec 31, 2020 3:18 pm

BioMedNewsBreaks – Why United Medical Equipment Business Solutions Network Inc. Is ‘One to Watch’

United Medical Equipment (“UME”) is a provider of reliable resources and solutions to fit the ever-changing needs of an aging population that includes seniors and veterans, as well as those impacted by the COVID-19 pandemic. The company is uniquely poised to offer health care across the continuum of care with solutions that help providers work more proficiently, health care systems work smarter, and patients live healthier lives. UME operates nationwide with a corporate office located in Fort Worth, Texas. A recent article discussing the company reads, “United Medical Equipment provides services that have been thoroughly vetted, have a good reputation,…

Continue Reading

ThursdayDec 31, 2020 2:56 pm

BioMedNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Eyes Expansion of Proprietary Imaging Technology

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, assists surgeons to more effectively root out cancers in a minimally invasive manner by making it possible to better see the interior recesses of men and women during medical procedures. The company will launch its platform with the introduction of the i/Blue Imaging (TM) System, a proprietary imaging technology based on advanced optics and light sensors. The value of Imagin’s platform is that it makes surgery-revolutionizing technology more available to hospitals through the ability to adapt it to existing equipment. A recent article discussing Imagin’s solution reads, “The company’s initial…

Continue Reading

WednesdayDec 30, 2020 3:11 pm

BioMedNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Secures Patent for Natural Biopesticide Treatment of Stored Produce, Foods

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural biological protection for high value crops, was recently granted an exclusive patent licensing from the University of Idaho in Moscow, Idaho (https://ibn.fm/EF2NV). According to the update, the patent is in connection with a natural biopesticide mustard-based treatment of stored produce and other foods. The treatment’s potential for sprout suppression of potatoes seems optimally timed, particularly amid increased interest in alternatives to chlorpropham (“CIPC”). The leading agrochemical product used for sprout suppression, CIPC is a critical element of potato storage. However, there are growing regulations to…

Continue Reading

WednesdayDec 23, 2020 2:44 pm

BioMedNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Integrates Data, AI to Pave Path for Better Health Outcomes

Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery, is positioned to play a critical role in the precision oncology industry. The company integrates AI technology with oncologists’ clinical decision-making processes, paving the way for improved health outcomes. A recent article discussing this reads, “POAI is focused on the use of data and artificial intelligence to develop personalized cancer therapies through its trove of valuable assets, including a database of clinically validated historical and outcome data from patient tumors, an in-house Clinical Laboratory Improvement Amendments (‘CLIA’)-certified…

Continue Reading

TuesdayDec 22, 2020 2:55 pm

BioMedNewsBreaks – Why RYAH Group Inc. Is ‘One to Watch’

RYAH Group is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through its IoT dose-measuring devices and AI analytics, RYAH is focused on expanding understanding of the value of devices combined with data to positively impact the future treatment of patients for various medical conditions. A recent article discussing the company reads, “Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed…

Continue Reading

TuesdayDec 22, 2020 2:41 pm

BioMedNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Takes Game-Changing Visualization Method to the Next Level

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, is at the forefront of change in its focus to establish a new standard of care in visualizing cancer. Minimally invasive surgery (“MIS”) using white light to illuminate tumor growth is the current standard of care for bladder cancer. This method is highly effective for visualizing cancerous tumors that protrude above the bladder’s wall. However, due to the difficulty in distinguishing flat tumors from normal tissue, it is nearly impossible to visualize the margins of the tumor under current standards. Game-changing to the industry has been the introduction of blue…

Continue Reading

TuesdayDec 22, 2020 2:28 pm

BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Aims to Identify Best Delivery Method for Lead Drug Candidate

AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, recently submitted a protocol amendment request to the U.S. Food and Drug Administration (“FDA”). Approval of the amendment will allow AzurRx to modify its current Phase 2b OPTION 2 trial of MS1819 in cystic fibrosis (“CF”) patients to add a study arm that uses immediate release capsules (https://ibn.fm/SxH8F). The existing study arm uses delayed release capsules, so the expansion will allow AzurRx to compare data from both arms to determine the best delivery method for its lead product, an exocrine pancreatic…

Continue Reading

FridayDec 18, 2020 2:24 pm

BioMedNewsBreaks – Why Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Is ‘One to Watch’

Imagin Medical (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company that is focused on establishing a new standard of care in visualizing cancer. The company’s initial focus is on bladder cancer and its first product is the i/Blue Imaging(TM) System. Based on advanced optics, light sensors and employing patented ultrasensitive imaging technology, Imagin believes its system can significantly improve surgeons’ ability to visualize and remove cancer cells. A recent article discussing the company reads, “Imagin Medical’s i/Blue Imaging System addresses the limitations of both white and blue light cystoscopies. The i/Blue System combines the white and blue light with…

Continue Reading

FridayDec 18, 2020 1:11 pm

BioMedNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Shines Spotlight on Innovative Media in Exclusive Interview

Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery, was recently featured in an exclusive audio interview with NetworkNewsWire. During the interview, POAI CEO Carl Schwartz noted recent milestones, outlined strategic goals and provided key updates on the company’s four impressive subsidiaries: Skyline Medical, TumorGenesis, Soluble Biotech and Helomics. Schwartz indicated that the original purpose of TumorGenesis was to develop a lab media to replace rats and mice in scientific industries as well as the testing of tumors. Predictive Oncology has succeeded in developing the first…

Continue Reading

FridayDec 11, 2020 2:45 pm

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Engages Dalmore Group for Expert Strategic Advice, Innovative Solutions

Brain Scientific (OTCQB: BRSF), a commercial-stage health-care company focused on developing innovative and proprietary medical devices and software, recently entered into a strategic partnership with the Dalmore Group. A member of FINRA and SIPC, the Dalmore Group maintains an active presence in the Regulation A+ equity funding space. The company is one of the world’s most active broker-dealers and has served on more than 50 RegA+ offerings in the past 12 months, raising more than $1 billion of capital in 2019. The Dalmore Group secures the majority of its clients by referral from securities attorneys and industry participants. A recent…

Continue Reading